Covid-19 news
We bring you the summary of the most relevant:
Wednesday June 2
WHO: only one variant from India is concerning
Only one of the three strains of the Covid-19 variant first detected in India is still considered “of concern”, while the other two have been degraded, the World Health Organization (WHO) said. Variant B.1.617, considered partially responsible for the outbreak of the pandemic in India, has spread to more than 50 territories, with three different lineages. (AFP)
Former President Felipe Calderón tests positive for covid-19
Former President Felipe Calderón (2006-2012) reported this Tuesday that he tested positive for Covid-19, and warned that he will remain isolated and at rest until he recovers from the disease. In a message through Twitter, Calderón, 58, reported his contagion while regretting not being able to accompany several candidates to their campaign closings this Wednesday. (EFE)
I thank the President @lopezobrador_ for his wishes for recovery. I still have mild symptoms and oxygenating very well.
– Felipe Calderón (@FelipeCalderon) June 2, 2021
Sinovac negotiates to expand supply to COVAX
The GAVI vaccine alliance is in talks with Chinese firm Sinovac Biotech to expand the portfolio of COVAX shared doses available to poor countries after the World Health Organization approved its Covid-19 drug on Tuesday, a spokeswoman said. of the group. “GAVI, on behalf of the COVAX program, is in dialogue with various manufacturers, including Sinovac, to further expand and diversify its portfolio and ensure access to additional doses for plan participants,” the spokeswoman said Wednesday. (Reuters)
Tuesday June 1
Variants of Covid-19 are named with the Greek alphabet
The World Health Organization (WHO) announced that it assigned each of the four variants of coronavirus considered worrisome names according to the Greek alphabet, which will make them easier to mention and remember. As in this type of situation, public opinion did not usually identify these variants by their scientific names (difficult to retain and differentiate), but by the place where they were initially detected, thus calling B.1.17 “British variant”, a B.1.351 “South African variant, P.1” Brazilian variant, and B.1.617.2 “Indian variant”, which has generated stigma and discrimination against the countries involved, as well as a certain degree of misinformation. (EFE)
Mexico will deliver mechanical respirators to 10 Latin American countries
The Ministry of Foreign Relations (SRE) of Mexico reported this Monday that it will deliver mechanical breathing medical devices, manufactured in the country, to ten nations in Latin America, given the health crisis that prevails worldwide due to the coronavirus pandemic. In this way, countries will serve people affected by Covid-19, as part of the Mesoamerica Project, a Mesoamerican integration and development program that enhances cooperation between countries. (EFE)
Mexico exceeds 40 million vaccines received
With the arrival of a batch of 288,990 doses of the Pfizer vaccine, Mexico adds 40.1 million doses against Covid-19, confirmed the Secretary of Foreign Relations, Marcelo Ebrard. The foreign minister explained that, after exceeding the ceiling of 40 million vaccines, Mexico is ranked ninth internationally in doses. Ebrard highlighted that the country is also ending production with packaging of the AstraZeneca vaccine, which will begin to be shipped to various countries in Latin America.
So we go at this time: pic.twitter.com/4IsdkhFGrr
– Marcelo Ebrard C. (@m_ebrard) June 1, 2021
Monday May 31
OECD recommends Mexico to accelerate vaccination
The acceleration in the vaccination campaign against Covid-19 is essential to revitalize the recovery of the Mexican economy, which will grow by 5% in 2021 and 3.2% in 2022, according to OECD estimates. In its semi-annual Outlook report, the Organization for Economic Cooperation and Development (OECD) pointed to forecasts for the Mexican economy similar to those predicted by the Ministry of Finance and Public Credit (SHCP), which are 5.3% for this year and 3.6% in 2022. (EFE)
#AmericaLatina is one of the regions hardest hit by # COVID19 and a slow recovery is in sight
What the countries of the region do now is decisive for the speed and type of recovery they can achieve. Https://t.co/HruLDRFNvu#PerspectivasEconmicasOECD pic.twitter.com/IbOGh1pavW– OECD ➡️ Better Policies for a Better Life (@ocdeenespanol) May 31, 2021
WHO Faces Possible Shakeup
The World Health Organization (WHO), at the center of the world’s slow and hesitant handling of the Covid-19 pandemic, is facing a possible shakeup aimed at preventing future epidemics from destroying lives and livelihoods. Health ministers agreed on Monday to study recommendations for ambitious reforms proposed by independent experts to strengthen the capacity of both the United Nations agency and countries to contain new pathogens. (Reuters)
Sheinbaum receives first dose of vaccine
The Head of Government of Mexico City, Claudia Sheinbaum, was vaccinated against Covid-19 this Saturday with the dose of Pfizer-BioNTech in a public center in the capital of the country. “Today I received my first dose of the covid-19 vaccine. I got number 178 for this day, ”the mayor said on social media. (EFE)
Thanks to my fellow doctors, nurses, citizen participation, the ponte pila program, servants of the Nation and Navy. Today I received my first dose of COVID-19 vaccine. I got number 178 today. 😊 pic.twitter.com/s47XpS7hsE
– Claudia Sheinbaum (@Claudiashein) May 29, 2021
EMA approves Pfizer for teens
The European Medicines Agency (EMA) today endorsed the use of the Pfizer / BioNTech vaccine for adolescents between 12 and 15 years old, the first preparation to pass European scientific scrutiny for minors, and advises injecting a second dose of AstraZeneca to adults who received an uncomplicated first. In a virtual press conference from the EMA headquarters in Amsterdam, Marco Cavaleri, Head of Vaccine Strategy, explained that the Committee for Medicinal Products for Human Use (CHMP) today approved the use of Pfizer’s vaccine in adolescents, a prepared against Covid-19 that was only authorized until now in the European Union (EU) for those over 16 years of age due to the lack of clinical studies that demonstrated its effectiveness in other age groups. (EFE)
